Precision Peptide advances thymosin alpha-1 patch into US testing
The company is moving its transdermal delivery formulation of the immune-modulating peptide into domestic evaluation.
PR
By Priya Raman · Science Reporter
Sep 11 06:37 ETSource: tipranks.com
The wire
- 01Precision Peptide Company said it is advancing a thymosin alpha-1 patch in US testing.
- 02Transdermal delivery could offer an alternative to injected peptide administration.
- 03Trial design, timing and regulatory pathway were not detailed.
From the source
Read at news.google.comPrecision Peptide Company Advances Thymosin Alpha-1 Patch in U.S. Testing